본문 바로가기
KERD
논문KCI 등재

Association between 14bp Insertion/Deletion Polymorphism in Exon 8 of HLA-G gene and Oral Squamous Cell Carcinoma in Korean Population

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류치의학

초록

Abnormal HLA-G expression occurs in various diseases such as melanoma, renal cell carcinoma, asthma, and classic Hodgkin’s lymphoma. The purpose of this study was to determine whether HLA-G gene is linked with oral squamous cell carcinoma (OSCC). To investigate the possible link with susceptibility to OSCC, 54 OSCC patients and 120 healthy controls were enrolled in this study. HLA-G 14bp insertion/deletion polymorphism is in 3'-untranslated region of HLA-G gene. HLA-G 14bp insertion/deletion polymorphism was analyzed using the polymerase chain reaction (PCR) method. For the analysis of genetic data, SPSS18.0 program was used. Logistic regression models were performed for odds ratio (OR), 95 percent confidence interval (CI), and P value. There was a significant difference in distribution allele between OSCC patients and control subjects (OR=0.018, 95% CI=0.002- 0.131, p<0.001). Our results suggest that HLA-G 14bp insertion/deletion polymorphism may be linked with susceptibility to OSCC in the Korean population.

Abstract

Abnormal HLA-G expression occurs in various diseases such as melanoma, renal cell carcinoma, asthma, and classic Hodgkin’s lymphoma. The purpose of this study was to determine whether HLA-G gene is linked with oral squamous cell carcinoma (OSCC). To investigate the possible link with susceptibility to OSCC, 54 OSCC patients and 120 healthy controls were enrolled in this study. HLA-G 14bp insertion/deletion polymorphism is in 3'-untranslated region of HLA-G gene. HLA-G 14bp insertion/deletion polymorphism was analyzed using the polymerase chain reaction (PCR) method. For the analysis of genetic data, SPSS18.0 program was used. Logistic regression models were performed for odds ratio (OR), 95 percent confidence interval (CI), and P value. There was a significant difference in distribution allele between OSCC patients and control subjects (OR=0.018, 95% CI=0.002- 0.131, p<0.001). Our results suggest that HLA-G 14bp insertion/deletion polymorphism may be linked with susceptibility to OSCC in the Korean population.

참고문헌 (26)

  1. Kamishikiryo, J, "HLA-G molecule", Curr Pharm Des, 15, pp.3318~3324 (2009)
  2. Margit Hørup Larsen, "Human leukocyte antigen-G polymorphism in relation to expression, function, and disease", Human Immunology, 70(12), pp.1026~1034 (2009), Elsevier BV[DOI]
  3. Rebmann, "Secretion of sHLA-G molecules in malignancies", Semin Cancer Biol, 13, pp.371~377 (2003)
  4. Michael Bezuhly, "Quantitative HLA-G Expression in Metastasising and Non-Metastasising Primary Thin Cutaneous Melanomas", Dermatology, 217(3), pp.281~283 (2008), S. Karger AG[DOI]
  5. Leos Kren, "Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia", macrophages in glioblastomas: A role in innate immunity?, 2010, pp.220(1-2), 131~135[DOI]
  6. Robert L. Elliott, "Human Leukocyte Antigen G Expression in Breast Cancer: Role in Immunosuppression", Cancer Biotherapy & Radiopharmaceuticals, 26(2), pp.153~157 (2011), Mary Ann Liebert Inc[DOI]
  7. M. Alvarez, "HLA-G 3′-UTR SNP and 14-bp deletion polymorphisms in Portuguese and Guinea-Bissau populations", International Journal of Immunogenetics, 36(6), pp.361~366 (2009), Wiley[DOI]
  8. Nahla Ghandri, "Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome", Human Immunology, 72(2), pp.150~158 (2011), Elsevier BV[DOI]
  9. E. C. Castelli, "HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population", Tissue Antigens, 72(2), pp.149~157 (2008), Wiley[DOI]
  10. Yuting Jiang, "Association of HLA-G 3' UTR 14-bp insertion", deletion polymorphism, 2011, pp.30(12), 1027~1032[DOI]
  11. P. Tripathi, "Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy", Tissue Antigens, 64(6), pp.706~710 (2004), Wiley[DOI]
  12. Vera Rebmann, "HLA-G expression in malignant melanoma", Seminars in Cancer Biology, 17(6), pp.422~429 (2007), Elsevier BV[DOI]
  13. Baricordi, "HLA-G and inflammatory diseases", Inflamm Allergy Drug Targets, 7, pp.67~74 (2008)
  14. Rouas-Freiss, "Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis", Proc Natl Acad Sci USA, 94, pp.11520~11525 (1997)
  15. Dara S. Berger, "Comprehensive Analysis of HLA-G: Implications for Recurrent Spontaneous Abortion", Reproductive Sciences, 17(4), pp.331~338 (2010), SAGE Publications[DOI]
  16. Takashi Kano, "Human Leukocyte Antigen May Predict Outcome of Primary Recurrent Spontaneous Abortion Treated with Paternal Lymphocyte Alloimmunization Therapy", American Journal of Reproductive Immunology, 58(4), pp.383~387 (2007), Wiley[DOI]
  17. Renata T Simões, "HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus", Modern Pathology, 22(8), pp.1075~1082 (2009), Springer Nature[DOI]
  18. X.-Q. Zheng, "The HLA-G 14 bp insertion", deletion polymorphism is a putative susceptible factor for active human cytomegalovirus infection in children, 2009, pp.74(4), 317~321[DOI]
  19. Segat, "HLA-G 3' UTR haplotypes and HIV vertical transmission", AIDS, 23, pp.1916~1918 (2009)
  20. Fabris, "Association between HLA-G 3'UTR 14-bp polymorphism and HIV vertical transmission in Brazilian children", AIDS, 23, pp.177~182 (2009)
  21. Emilie Lesport, "Human melanoma cell secreting human leukocyte antigen–G5 inhibit natural killer cell cytotoxicity by impairing lytic granules polarization toward target cell", Human Immunology, 70(12), pp.1000~1005 (2009), Elsevier BV[DOI]
  22. Mirjana Urosevic, "HLA-G and its KIR ligands in cancer - another enigma yet to be solved?", The Journal of Pathology, 196(3), pp.252~253 (2002), Wiley[DOI]
  23. Cordero, "HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients", Tissue Antigens, 74, pp.308~313 (2009)
  24. D. Piancatelli, "HLA-G 14-bp Insertion", Deletion Polymorphism in Kidney Transplant Patients With Metabolic Complications, 2009, pp.41(4), 1187~1188[DOI]
  25. X.-Y. Chen, "The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma", Tissue Antigens, 72(4), pp.335~341 (2008), Wiley[DOI]
  26. F-X. Wu, "Lack of association between HLA-G 14-bp polymorphism and systemic lupus erythematosus in a Han Chinese population", Lupus, 18(14), pp.1259~1266 (2009), SAGE Publications[DOI]

관련 논문AI추천

14-bp Insertion/Deletion Polymorphism of the HLA-G Gene in Osteosarcoma Patients김수강, 김윤화, 나기용, 문아림, 박용구, 정주호, Eduardo Santini-Araujo, Liliana G. Olvi대한병리학회 · Journal of Pathology and Translational Medicine2011 · 제45권 제5호난소암 조직에서 HLA-G유전자 발현과예후 인자와의 상관성김상운, 김성훈, 김영태, 김재욱, 김재훈, 박용원, 윤보성, 홍원기대한산부인과학회 · Obstetrics & Gynecology Science2005 · 제48권 제12호XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck in a Korean Sample태경, 김경래, 박철원, 신형두, 이승환, 이윤서, 지용배, Byung Lae Park대한이비인후과학회 · Clinical and Experimental Otorhinolaryngology2010 · 제3권 제1호한국인 구강 편평세포암에서 Glutathione S-transferase와 CYP1A1 유전자의 다형성권종진, 박광균, 차인호대한구강악안면외과학회 · 대한구강악안면외과학회지2002 · 제28권 제5호자궁경부암에서 HLA-G와 IL-10의 발현 및 상호작용김상운, 김성훈, 김영태, 김재욱, 김재훈, 남은지, 윤보성대한산부인과학회 · Obstetrics & Gynecology Science2007 · 제50권 제1호Gender-specific Association between Polymorphism of Vascular Endothelial Growth Factor (VEGF 936C>T) Gene and Patients with Stomach Cancer강혜윤, 김남근, 배수진, 안대호, 오도연, 홍성표, 황성규연세대학교의과대학 · Yonsei Medical Journal2008 · 제49권 제5호

이 간행물의 다른 논문 (5건)